Introduction
Concerns are increasing in the EU about the use of chemicals employed in the manufacture of the recreational drug GHB. The report GHB and its precursor GBL: an emerging trend case study is published as part of the EMCDDA's E-POD project to track new patterns of drug use in Europe.
Download as PDF
Table of contents
- About the E-POD project
- Introduction
- Description
- Prevalence and use patterns
- Markets and availability
- Dose and effects
- Negative health consequences
- Conclusions